How to Save Money on Tesamorelin in 2026: Coupons, Discounts, and Patient Assistance

Tesamorelin — sold as Egrifta SV and the newer Egrifta WR — is one of the most expensive prescription medications available. Brand-name Egrifta can cost between $2,400 and $2,800 per month at retail, and there is no FDA-approved generic. If you have been prescribed tesamorelin for HIV-associated lipodystrophy, the good news is that multiple financial assistance programs exist specifically to help patients access this medication at a manageable cost. Here is a complete guide to every savings option available in 2026.

Why Does Tesamorelin Cost So Much?

Tesamorelin is a specialty biologic drug — a synthetic peptide produced through complex pharmaceutical manufacturing. It is the only FDA-approved medication for HIV lipodystrophy, which gives the manufacturer, Theratechnologies, significant pricing power through patent exclusivity. The drug is classified as a specialty-tier (Tier 4 or 5) medication by most insurance plans, which means even insured patients typically face higher cost-sharing. There is no FDA-approved generic, though compounded versions are available at lower prices.

Option 1: The THERA Co-Pay Assistance Program (Best for Commercially Insured Patients)

If you have private or commercial health insurance from your employer or purchased directly from an insurer, the THERA Co-Pay Assistance Program may significantly reduce your out-of-pocket cost for Egrifta WR or Egrifta SV. This is a manufacturer-sponsored program run through the THERA Patient Support infrastructure.

To access this program: Ask your doctor to enroll you in the THERA Patient Support program at the time of prescribing (or contact 1-833-23-THERA yourself). Once enrolled, a Patient Care Coordinator will determine your eligibility for the co-pay program and set it up for you. Note: This program does not apply to patients with government insurance (Medicare, Medicaid, or other federal programs).

Option 2: The THERA Patient Assistance Program (For Qualifying Uninsured/Underinsured Patients)

If you do not have insurance, or your insurance won't cover tesamorelin, you may qualify for the THERA Patient Assistance Program. This program provides tesamorelin at no cost to qualifying patients. Eligibility is based on income, insurance status, and medical need.

Contact THERA Patient Support at 1-833-23-THERA (1-833-238-4372) to find out if you qualify. Your doctor can also initiate enrollment on your behalf through the provider portal at hcp.egriftawr.com.

Option 3: Government Insurance Resources (Medicare and Medicaid)

Tesamorelin is covered under Medicare Part D (prescription drug plans), classified as a specialty-tier medication. Copays for specialty drugs can be high, but starting in 2025, the Medicare Part D out-of-pocket maximum is $2,000 per year — which caps your annual total drug spending. Once you reach the out-of-pocket maximum, your plan covers 100% of the cost for the rest of the year.

For Medicare patients, THERA Patient Support can help explore additional resources to lower out-of-pocket costs, including alternative funding programs. Medicaid coverage varies significantly by state — your specialty pharmacy and THERA Patient Support can verify coverage for your specific Medicaid plan.

Option 4: HIV-Specific Assistance Programs

Because tesamorelin is indicated specifically for HIV-associated lipodystrophy, HIV-specific assistance programs may help cover costs. These include:

Ryan White HIV/AIDS Program: Federal program that provides funding for HIV-related health services for people with limited incomes. Depending on your state and local Ryan White grantee, some drug costs may be covered.

AIDS Drug Assistance Programs (ADAPs): State-administered programs that help low-income HIV patients access medications. ADAP formularies vary by state — check whether tesamorelin is covered in your state's ADAP.

Option 5: Compounded Tesamorelin (Cash-Pay Alternative)

Compounded tesamorelin from licensed 503A and 503B pharmacies costs significantly less than brand-name Egrifta — typically $150 to $1,200 per month depending on the pharmacy type and dose. This is a cash-pay option that is not covered by insurance.

Important caveats: Compounded tesamorelin is not FDA-approved. The FDA has raised regulatory concerns about compounded peptides. Quality varies by pharmacy. Never purchase tesamorelin from sources that do not require a valid prescription from a licensed U.S. provider. Always discuss compounded tesamorelin with your doctor before pursuing this option.

Option 6: Prescription Hope Advocacy Services

Prescription Hope is a third-party medication access service that works directly with pharmaceutical manufacturers' patient assistance programs to help patients obtain brand-name medications. They charge a service fee of $70 per month per medication and work on your behalf to navigate patient assistance programs. This is not an insurance plan or a drug discount card — it is an advocacy service that helps you apply for manufacturer assistance programs.

Summary: Your Savings Roadmap for Tesamorelin

Have commercial insurance → Ask about the THERA Co-Pay Assistance Program (1-833-23-THERA)

Have no insurance or denied coverage → Apply for the THERA Patient Assistance Program (free drug for qualifying patients)

Have Medicare → The $2,000/year Part D out-of-pocket cap helps; explore additional resources with THERA support

Low-income HIV patient → Ask your doctor about Ryan White and ADAP programs in your state

Once you've sorted out the cost side, make sure you can actually get your prescription filled. Use medfinder to find specialty pharmacies near you that have tesamorelin in stock. And read our guide on how to find tesamorelin in stock near you for more strategies.